Aspen Pharmacare Holdings (LDZA) Stock Statistics & Valuation Metrics
Total Valuation
Aspen Pharmacare Holdings has a market cap or net worth of EUR 3.67B. The enterprise value is EUR 4.22B.
- Market Cap
- EUR 3.67B
- Enterprise Value
- EUR 4.22B
Share Statistics
Aspen Pharmacare Holdings has 432,921,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 432,921,450
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Aspen Pharmacare Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.28%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 4.28%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 5.86M
- Profits Per Employee
- 577.57K
- Employee Count
- 7,625
- Asset Turnover
- 0.32
- Inventory Turnover
- 1.40
Valuation Ratios
The current PE Ratio of Aspen Pharmacare Holdings is 11.26. Aspen Pharmacare Holdings’s PEG ratio is 6.57.
- PE Ratio
- 11.26
- PS Ratio
- 1.11
- PB Ratio
- 0.59
- Price to FCF
- 18.34
- Price to Operating Cash Flow
- 9.05
- PEG Ratio
- 6.57
Income Statement
In the last 12 months, Aspen Pharmacare Holdings had revenue of 44.71B and earned 4.40B in profits. Earnings per share was 9.91.
- Revenue
- 44.71B
- Gross Profit
- 19.45B
- Operating Income
- 7.00B
- Pretax Income
- 5.71B
- Net Income
- 4.40B
- EBITDA
- 9.91B
- Earnings Per Share (EPS)
- 9.91
Cash Flow
In the last 12 months, operating cash flow was 6.16B and capital expenditures -4.46B, giving a free cash flow of 1.72B billion.
- Operating Cash Flow
- 6.16B
- Free Cash Flow
- 1.72B
- Free Cash Flow per Share
- 6.19
Dividends & Yields
Aspen Pharmacare Holdings pays an annual dividend of ―, resulting in a dividend yield of 1.59%
- Dividend Per Share
- ―
- Dividend Yield
- 1.59%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.45%
- Earnings Yield
- 8.88%
Stock Price Statistics
- Beta
- 0.35
- 52-Week Price Change
- 73.24%
- 50-Day Moving Average
- 8.19
- 200-Day Moving Average
- 7.32
- Relative Strength Index (RSI)
- 51.73
- Average Volume (3m)
- 483
Important Dates
Aspen Pharmacare Holdings upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 02, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- ―
Financial Position
Aspen Pharmacare Holdings as a current ratio of 1.81, with Debt / Equity ratio of 42.96%
- Current Ratio
- 1.81
- Quick Ratio
- 1.07
- Debt to Market Cap
- 0.36
- Net Debt to EBITDA
- 2.43
- Interest Coverage Ratio
- 3.14
Taxes
In the past 12 months, Aspen Pharmacare Holdings has paid 1.31B in taxes.
- Income Tax
- 1.31B
- Effective Tax Rate
- 0.23
Enterprise Valuation
Aspen Pharmacare Holdings EV to EBITDA ratio is 7.26, with an EV/FCF ratio of 28.76.
- EV to Sales
- 1.74
- EV to EBITDA
- 7.26
- EV to Free Cash Flow
- 28.76
- EV to Operating Cash Flow
- 14.20
Balance Sheet
Aspen Pharmacare Holdings has EUR 12.34B in cash and marketable securities with EUR 36.46B in debt, giving a net cash position of -EUR 24.12B billion.
- Cash & Marketable Securities
- EUR 12.34B
- Total Debt
- EUR 36.46B
- Net Cash
- -EUR 24.12B
- Net Cash Per Share
- -EUR 55.71
- Tangible Book Value Per Share
- EUR 31.11
Margins
Gross margin is 45.16%, with operating margin of 18.85%, and net profit margin of 9.84%.
- Gross Margin
- 45.16%
- Operating Margin
- 18.85%
- Pretax Margin
- 13.16%
- Net Profit Margin
- 9.84%
- EBITDA Margin
- 23.95%
- EBIT Margin
- 20.64%
Analyst Forecast
The average price target for Aspen Pharmacare Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -19.32%
- EPS Growth Forecast
- ―
